1
Total investments
0
Early stage
1
Mid stage
0
Late stage
7y
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jul 2019
Engineers deserve a better way to collaborate. Imagine a solution that eliminates the hassles of traditional collaboration systems, like email chains, spreadsheets, PowerPoint, and costly factory visits.
Imagine a platform where you can store CAD designs, granting easy access for authorized users to view 3D files and sections and hide assembly parts, empowering production teams to solve issues independently. Imagine diving into CAD models online without downloads or expensive software, working seamlessly across devices. Now, add the power to accelerate time-to-market with integrated online manufacturing solutions like DFM support and instant RFQs at the best prices.
Wikifactory offers a unique approach, standing at the intersection of PLM, CAD tools, and Online Manufacturing, streamlining workflows with zero bottlenecks, allowing you to innovate and launch products quickly without development roadblocks. Say goodbye to being stuck in the development process, to working in silos, to having to worry about how to get anyone in one place, to lack of overview, to supply chain issues, and more.
Wikifactory is the only cloud-based collaborative platform for easy CAD access, real-time 3D feedback, hassle-free file management, remote access and collaboration versatility, and cost-effective manufacturing with expert support.
From iteration to production, weve got you covered.
Experience · 5 entries
All (5)
Investments (1)
Board (1)
2019
Board Member
Jul 2019
Engineers deserve a better way to collaborate. Imagine a solution that eliminates the hassles of traditional collaboration systems, like email chains, spreadsheets, PowerPoint, and costly factory visits.
Imagine a platform where you can store CAD designs, granting easy access for authorized users to view 3D files and sections and hide assembly parts, empowering production teams to solve issues independently. Imagine diving into CAD models online without downloads or expensive software, working seamlessly across devices. Now, add the power to accelerate time-to-market with integrated online manufacturing solutions like DFM support and instant RFQs at the best prices.
Wikifactory offers a unique approach, standing at the intersection of PLM, CAD tools, and Online Manufacturing, streamlining workflows with zero bottlenecks, allowing you to innovate and launch products quickly without development roadblocks. Say goodbye to being stuck in the development process, to working in silos, to having to worry about how to get anyone in one place, to lack of overview, to supply chain issues, and more.
Wikifactory is the only cloud-based collaborative platform for easy CAD access, real-time 3D feedback, hassle-free file management, remote access and collaboration versatility, and cost-effective manufacturing with expert support.
From iteration to production, weve got you covered.
2016
W
World Refugee School
Managing Director
Dec 2016
Board Director
Apr 2016
BioPorto Diagnostics A/S is a Danish in-vitro diagnostic company that provides biomarkers, research antibodies and assays to scientists and clinicians worldwide. We use our antibody and assay expertise to transform novel research tools into clinically actionable assays that can make a difference in patients’ lives.
Our flagship product, The NGAL Test™, aids in the rapid risk assessment of acute kidney injury (AKI) in critically ill patients by measuring the NGAL biomarker associated with renal tubular injury. AKI is common among hospitalized patients, affecting 1 in 5 adults and 1 in 4 children. It is often asymptomatic and can be difficult to identify. To learn more about this public health concern, visit https://bioporto.com/aki/.
Designed to run on standard chemistry analyzers, The NGAL Test is CE marked and available for IVD use in the EU, Canada, Korea and Israel, and is for research use only in all other regions.
BioPorto Diagnostics’ patented generic Rapid Assay Device (gRAD) is a platform technology that is designed to facilitate the fast and easy development of custom lateral flow assays. It has been used in a variety of research projects including to determine levels of NGAL, and to quantify levels of thrombomodulin in early sepsis. Currently, gRAD is also being investigated for potential COVID-19 applications.
We also offer highly specific antibodies suitable for research into clinical conditions such as AKI, obesity, diabetes, innate immunity, allergy and infectious diseases.
Headquartered in Hellerup, Denmark, BioPorto A/S is listed on the NASDAQ Copenhagen stock exchange. [CPH: BIOPOR]
To learn more about our products and their availability in your country, please visit https://bioporto.com/products/.
Posts are not intended for a U.S. audience. If you are from the United States, you are encouraged to visit https://www.linkedin.com/company/bioporto-diagnostics-inc-us/
Social Media Community Guidelines: https://bioporto.com/social-media/
2013
Chairman
Apr 2013
High quality, results-oriented English learning on the Web – that’s Savivos Mission!
Savivo has grown into one of the largest English learning communities online, where kids learn English by taking advantage of Mingoville’s cutting-edge technologies and easy-to-use interactive Web-based interface that can be accessed from any computer with an Internet connection 24 / 7.
Based in Copenhagen and founded in early 2000, the mission and vision of Savivo is to bring education to life and in doing so, awaken a love for learning in children. As an award-winning education e-games and apps developer, we have the winning formula to create fun, innovative and savvy games to give children a winning head start in life.
We embrace a unique learning philosophy in our innovation, with learner-centered and self-directed learning pedagogies underpinning our e-learning products. And we believe in fostering strategic partnerships with global institutions and governments to fight illiteracy, break down global and social barriers to empower children all over the world.
2011
Board Director
2011
The QuantumATK team at Synopsys develops the QuantumATK simulation tool for fast and reliable atomic-scale modeling of nanostructure. QuantumATK is fully supported and delivered in an easy-to-use interface, tailored from state-of-the-art methods, and developed by experts to the specifications of our customers.
Who we are
The QuantumATK team are former employees of QuantumWise which was acquired by Synopsys Inc. in 2017. At present, the QuantumATK team are part of Synopsys TCAD and has more than 30 employees, working with developing the QuantumATK code and supporting the users. Most of the employees have a Ph.D. in physics or chemistry, and/or are seasoned programmers with long experience in numerical modeling and GUI development.
Our aim and philosophy
We position ourselves as a facilitator by interacting with both the research community to extract the latest state-of-the-art methods and techniques, and with researchers in companies and universities that seek to utilize these tools. We strive to deliver these advanced numerical tools in an easy-to-use package. Our primary aim is to make the latest developments within atomic-scale modeling available to enable technologists to solve real life problems within the materials and semiconductor industry.
Unlike most other commercial companies offering software for atomic-scale modeling, we develop our own code from the bottom up, and we have the in-house expertise to develop novel functionality all the way down to the quantum-mechanical level. Our software is a constant work in progress, and our development is test-driven and guided by customer requests and requirements. We spend a lot of energy on ensuring the quality and reliability of the software.
Can we help you solve a problem?
If you have any questions related to our products or company, please get in touch with us (quantumatk@synopsys.com), as we would love to hear from you! Requests and feedback from our customers is what helps us evolve our products.